The Full Wiki

More info on Zanolimumab

Zanolimumab: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Zanolimumab ?
Monoclonal antibody
Source Human
Target CD4
Identifiers
CAS number 652153-01-0
ATC code none
PubChem  ?
Chemical data
Formula  ?
Mol. mass 147 kDa
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

Zanolimumab (expected trade name HuMax-CD4[1]) is a human monoclonal antibody and an immunosuppressive drug. It is being developed for the treatment of rheumatoid arthritis, psoriasis, cutaneous and peripheral T-cell lymphoma.[2][3]

References

  1. ^ Genmab initiates Phase II Study with HuMax-CD4
  2. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Zanolimumab, American Medical Association.
  3. ^ ClinicalTrials.gov NCT00042406 Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-Alpha Blocker
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message